Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes

Fig. 2

Fluvoxamine inhibits the activation of CD4+ T cells but does not affect dendritic cells, macrophages, and CD8+ T cells in the pancreatic lymph nodes (PLNs). PLN cells from 12-week-old fluvoxamine-treated and vehicle-treated mice were harvested and subject to flow cytometry analysis. Representative FACS plots of A DCs (MHCII+CD11C+) and B analysis of the MFI of CD80 and CD86. Representative FACS plots of C macrophages (CD11b+F4/80+) and D analysis of the MFI of CD80 and CD86. The frequencies of E CD4+, F CD8+, G CD4+CD44highCD62Llo (CD4 effector T cells) and H CD8+CD44highCD62Llo (CD8 effector T cells) are shown (n = 5 per group). Data are expressed as mean ± SEM. Statistical significance was calculated by unpaired Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001, and ns, not significant

Back to article page